BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36648781)

  • 21. Cutaneous inflammatory myofibroblastic tumor with CARS-ALK fusion: Case report and literature review.
    McCollum KJ; Jour G; Al-Rohil RN
    J Cutan Pathol; 2022 Sep; 49(9):795-801. PubMed ID: 35560368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor.
    Debelenko LV; Arthur DC; Pack SD; Helman LJ; Schrump DS; Tsokos M
    Lab Invest; 2003 Sep; 83(9):1255-65. PubMed ID: 13679433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Durable Clinical Response to ALK Tyrosine Kinase Inhibitors in Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring
    Wang Z; Geng Y; Yuan LY; Wang MM; Ye CY; Sun L; Dai WP; Zang YS
    Front Oncol; 2022; 12():761558. PubMed ID: 35237506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
    Parker BM; Parker JV; Lymperopoulos A; Konda V
    J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelioid cell histiocytoma with SQSTM1-ALK fusion: a case report.
    Nakayama R; Togashi Y; Baba S; Kaku Y; Teramoto Y; Sakurai T; Haga H; Takeuchi K
    Diagn Pathol; 2018 May; 13(1):28. PubMed ID: 29747676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DCTN1-ALK gene fusion in inflammatory myofibroblastic tumor (IMT) of the CNS.
    Vidrine DW; Berry JF; Garbuzov A; Falcon C; Tubbs RS; Bui CJ
    Childs Nerv Syst; 2021 Jul; 37(7):2147-2151. PubMed ID: 34014367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases.
    Li XQ; Hisaoka M; Shi DR; Zhu XZ; Hashimoto H
    Hum Pathol; 2004 Jun; 35(6):711-21. PubMed ID: 15188137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelioid inflammatory myofibroblastic sarcoma of stomach: diagnostic pitfalls and clinical characteristics.
    Xu P; Shen P; Jin Y; Wang L; Wu W
    Int J Clin Exp Pathol; 2019; 12(5):1738-1744. PubMed ID: 31933992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib.
    Li M; Xing R; Huang J; Shi C; Wei C; Wang H
    Front Oncol; 2023; 13():1084456. PubMed ID: 37035183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALK-Rearranged Epithelioid and Spindle Cell Neoplasm of the Sinonasal Tract.
    Zhu P; Wang J
    Int J Surg Pathol; 2024 Feb; ():10668969241226699. PubMed ID: 38303518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary epithelioid inflammatory myofibroblastic sarcoma of the brain with EML4::ALK fusion mimicking intra-axial glioma: a case report and brief literature review.
    Kim EE; Park CK; Kang KM; Kwak Y; Park SH; Won JK
    J Pathol Transl Med; 2024 May; 58(3):141-145. PubMed ID: 38766740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical fibrous histiocytoma of the skin with CD30 and p80/ALK1 positivity and ALK gene rearrangement.
    Szablewski V; Laurent-Roussel S; Rethers L; Rommel A; Van Eeckhout P; Camboni A; Willocz P; Copie-Bergman C; Ortonne N
    J Cutan Pathol; 2014 Sep; 41(9):715-9. PubMed ID: 24666231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraarticular Inflammatory Myofibroblastic Tumor of the Left Knee With ALK-CARS Fusion Detected With Archer Fusionplex Sarcoma NGS Panel: Case Report and Literature Review.
    Pineda-Díaz J; Solar I; Hershkovitz D; Drukman I; Sher O
    Int J Surg Pathol; 2021 Apr; 29(2):216-222. PubMed ID: 32631118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
    Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
    Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review.
    Singh P; Nambirajan A; Gaur MK; Raj R; Kumar S; Malik PS; Jain D
    J Pathol Transl Med; 2022 Jul; 56(4):231-237. PubMed ID: 35843628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "Chondroblastoma-like" epithelioid fibrous histiocytoma: A previously undescribed and potentially confusing variant.
    Martinez AP; Zou Y; Billings SD; Folpe AL
    J Cutan Pathol; 2018 Feb; 45(2):99-103. PubMed ID: 29068085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report.
    Honda K; Kadowaki S; Kato K; Hanai N; Hasegawa Y; Yatabe Y; Muro K
    Invest New Drugs; 2019 Aug; 37(4):791-795. PubMed ID: 30790150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Cutaneous Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring RANBP2-ALK Fusion: Report of an Exceptional Case.
    Gadeyne L; Creytens D; Dekeyser S; Van der Meulen J; Haspeslagh M
    Am J Dermatopathol; 2022 Apr; 44(4):302-305. PubMed ID: 34816804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case report:
    Sheng SJ; Li JM; Fan QH; Liu Y; Chen SY; Zhao M; Gong QX
    Front Oncol; 2022; 12():1007296. PubMed ID: 36387173
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.